CRP and non-small cell lung carcinoma: First, to evaluate I-CRP cytotoxicity in non-small cell lung cancer (NSCLC) cell lines, we assessed indirect cell viability through MTT assay in A549, A427, CALU-1, and INER-51 lung carcinoma cells.